AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Letshil 2.5mg Tablet

Prescription Icon
Prescription Required

Marketer

Shilpa Medicare Ltd

Salt Composition

Letrozole (2.5mg)

Overview Letshil 2.5mg Tablet

Postmenopausal women with breast cancer may find relief with Letshil 2.5mg Tablets. This medication can be a standalone treatment or used alongside surgery or radiotherapy. In advanced breast cancer, it helps prevent metastasis. Letshil 2.5mg Tablets may be ingested with or without food, always following your physician's prescribed dosage and duration for optimal results. Dosage frequency is determined by the specific application. Your doctor will adjust your prescription to best manage your symptoms. Continue taking this medication as directed. Common side effects include increased perspiration, weariness, hot flashes, and elevated cholesterol (hypercholesterolemia). Report any concerning side effects to your doctor, who can offer mitigating strategies. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, or a history of osteoporosis. A complete list of current medications should also be provided, as interactions can affect Letshil's efficacy. Disclose any pregnancy or breastfeeding to your physician. Pre- and ongoing treatment may involve blood tests to monitor vitamin D levels and bone density.

Primary Ingredients of Letshil 2.5mg Tablet

No text provided. Please provide the text you would like me to rephrase.

Uses of Letshil 2.5mg Tablet

Managing breast cancer

Major Benefits of Letshil 2.5mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Letshil 2.5mg Tablets can be consumed with or without food, though consistent timing is recommended.

Common Side effects of Letshil 2.5mg Tablet:

  • Dizziness
  • Fatigue
  • Weakness
  • Bone pain
  • Back pain
  • Night sweats
  • Joint pain
  • Nausea
  • Osteoporosis
  • Joint inflammation
  • Weight gain
  • Hot flushes
  • Edema (swelling)
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Diaphoresis
  • Bone fracture
  • Hypercholesterolemia (high cholesterol)
  • Cough
  • Shortness of breath

How to use Letshil 2.5mg Tablet:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Letshil 2.5mg Tablets can be consumed with or without food, although consistent timing is recommended.

How Letshil 2.5mg Tablet works:

Estrogen production is reduced by Letshil 2.5mg tablets, a medication classified as an aromatase inhibitor. This lowered estrogen level inhibits the growth of certain estrogen-dependent breast cancers.

SAFETY ADVICE

AlcoholAlcoholSAFE

Letshil 2.5mg Tablet's concurrent use with alcohol presents no known adverse reactions.

PregnancyPregnancyUNSAFE

Using Letshil 2.5mg tablets during pregnancy poses a considerable risk. Pregnant women should consult their physician; research in animals and pregnant humans indicates substantial harm to the fetus.

Breast feedingBreast feedingUNSAFE

Lactation and Letshil 2.5mg tablets are incompatible. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingUNSAFE

Driving may be impaired by Letshil 2.5mg Tablets, which can cause drowsiness, dizziness, and blurred vision. Refrain from operating a vehicle if these effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

The 2.5mg Letshil tablet presents a safe treatment option for individuals with kidney impairment, requiring no dosage modification. Data regarding its use in patients with terminal kidney disease remains scarce. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Letshil 2.5mg tablets. Dosage modification may be necessary; physician consultation is advised.

What if you forget to take Letshil 2.5mg Tablet :

Should you forget a Letshil 2.5mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Letshil 2.5mg Tablet

LabelValue
Chemical Category Diphenylmethane-based compound
Developing Habits No.
Type of Therapy Cancer Medications

FAQs on Letshil 2.5mg Tablet

Letshil 2.5mg tablets are aromatase inhibitors used to treat breast cancer in postmenopausal women.
Letshil 2.5mg tablets are anti-estrogen medications. They work by inhibiting aromatase, an enzyme that produces estrogen. This reduces estrogen levels, which can help prevent the growth of estrogen-dependent breast cancers.
For advanced breast cancer or cancer that has spread, continue Letshil 2.5mg Tablet until tumor progression. Following tamoxifen or surgery, take Letshil 2.5mg Tablet for five years or until recurrence, whichever occurs first. Alternatively, a sequential regimen of two years of Letshil 2.5mg Tablet followed by three years of tamoxifen may be used.
While irbesartan and Letshil 2.5mg Tablet can be taken together, monitor your blood pressure closely as Letshil 2.5mg Tablet may elevate it. Consult your doctor if blood pressure management becomes difficult.
While rare, Letshil 2.5mg Tablet may cause cataracts. Report blurred vision or eye irritation to your doctor promptly.
Letshil 2.5mg Tablet can sometimes cause hot flushes, a common side effect resulting from decreased estrogen. These usually lessen as your body adapts to the medication. However, they may persist throughout treatment and subside only after it ends. If hot flushes are severe, consult your doctor for management options.
While rare, Letshil 2.5mg Tablet may cause serious side effects such as stroke, angina, heart attack, blood clots, cataracts, osteoporosis, and severe skin reactions.
Letshil 2.5mg Tablets can weaken bones (osteoporosis) by lowering estrogen levels. Your doctor may monitor your bone density before, during, and after treatment to detect osteoporosis.
The Ministry of Health and Family Welfare restricts Letshil 2.5mg Tablets to inducing ovulation in women with anovulatory infertility.
Letshil 2.5mg Tablet
129
MRP 150
14% off